Total Payments
$679.28
2024 Payments
$54.77
Companies
10
Transactions
16
Medicare Patients
960
Medicare Billing
$88,656
Payment Breakdown by Category
Food & Beverage$639.60 (94.2%)
Education$39.68 (5.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $639.60 | 14 | 94.2% |
| Education | $39.68 | 2 | 5.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $392.67 | 5 | $0 (2022) |
| Intuitive Surgical, Inc. | $62.36 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $52.57 | 3 | $0 (2019) |
| Mylan Specialty L.P. | $37.17 | 1 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $30.31 | 1 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.78 | 1 | $0 (2017) |
| ZOLL Respicardia, Inc. | $21.62 | 1 | $0 (2023) |
| Circassia Pharmaceuticals Inc | $20.54 | 1 | $0 (2017) |
| Insmed, Inc. | $17.60 | 1 | $0 (2024) |
| Grifols USA, LLC | $16.66 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $54.77 | 2 | Mylan Specialty L.P. ($37.17) |
| 2023 | $21.62 | 1 | ZOLL Respicardia, Inc. ($21.62) |
| 2022 | $233.87 | 4 | AstraZeneca Pharmaceuticals LP ($124.54) |
| 2021 | $131.24 | 2 | AstraZeneca Pharmaceuticals LP ($131.24) |
| 2019 | $37.57 | 2 | GlaxoSmithKline, LLC. ($37.57) |
| 2018 | $26.90 | 2 | GlaxoSmithKline, LLC. ($15.00) |
| 2017 | $173.31 | 3 | AstraZeneca Pharmaceuticals LP ($124.99) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Respiratory | ||||||
| 09/25/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $37.17 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/08/2023 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $21.62 | General |
| Category: Respiratory | ||||||
| 09/09/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $30.31 | General |
| Category: IMMUNOLOGY | ||||||
| 07/08/2022 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Pulmonology | ||||||
| 06/01/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.54 | General |
| Category: Respiratory | ||||||
| 01/04/2022 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $62.36 | General |
| Category: SURGERY | ||||||
| 06/02/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 04/26/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: Respiratory | ||||||
| 11/22/2019 | GlaxoSmithKline, LLC. | ANORO (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2019 | GlaxoSmithKline, LLC. | ANORO (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: RESPIRATORY | ||||||
| 06/11/2018 | AstraZeneca Pharmaceuticals LP | — | Education | In-kind items and services | $11.90 | General |
| 04/18/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA (Drug) | Education | In-kind items and services | $27.78 | General |
| Category: RESPIRATORY | ||||||
| 03/13/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 02/27/2017 | Circassia Pharmaceuticals Inc | NIOX VERO DEVICE (Device) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: ALLERGY AND ASTHMA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 241 | 347 | $54,735 | $23,813 |
| 2022 | 4 | 227 | 344 | $49,650 | $21,933 |
| 2021 | 5 | 242 | 352 | $54,786 | $23,678 |
| 2020 | 6 | 250 | 318 | $52,359 | $19,231 |
Total Patients
960
Total Services
1,361
Medicare Billing
$88,656
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 126 | 213 | $32,378 | $13,895 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 63 | $13,524 | $6,133 | 45.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $6,385 | $2,694 | 42.2% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 19 | 23 | $1,289 | $597.31 | 46.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 25 | 26 | $1,159 | $493.92 | 42.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 125 | 227 | $32,733 | $14,902 | 45.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 54 | 65 | $13,594 | $5,892 | 43.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 32 | 36 | $2,311 | $722.02 | 31.2% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 16 | 16 | $1,012 | $417.87 | 41.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 125 | 203 | $30,001 | $12,936 | 43.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 61 | 89 | $19,097 | $8,718 | 45.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $2,334 | $883.40 | 37.9% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 29 | 30 | $2,087 | $667.29 | 32.0% |
| 94618 | Test for exercise-induced lung stress | Office | 2021 | 16 | 19 | $1,267 | $473.94 | 37.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 117 | 176 | $26,011 | $9,550 | 36.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 50 | 56 | $12,016 | $4,564 | 38.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 19 | 19 | $6,167 | $2,208 | 35.8% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 25 | 25 | $5,304 | $1,877 | 35.4% |
| 94618 | Test for exercise-induced lung stress | Office | 2020 | 18 | 21 | $1,400 | $534.87 | 38.2% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 21 | 21 | $1,461 | $497.74 | 34.1% |
About Dr. Virginia Rowland, MD
Dr. Virginia Rowland, MD is a Pulmonary Disease healthcare provider based in Gold Canyon, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134132772.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Virginia Rowland, MD has received a total of $679.28 in payments from pharmaceutical and medical device companies, with $54.77 received in 2024. These payments were reported across 16 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($639.60).
As a Medicare-enrolled provider, Rowland has provided services to 960 Medicare beneficiaries, totaling 1,361 services with total Medicare billing of $88,656. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Gold Canyon, AZ
- Active Since 08/14/2006
- Last Updated 10/03/2012
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1134132772
Products in Payments
- BREZTRI (Drug) $249.53
- BEVESPI AEROSPHERE (Drug) $124.99
- Da Vinci Surgical System (Device) $62.36
- ANORO (Drug) $37.57
- YUPELRI (Drug) $37.17
- ACTHAR (Biological) $30.31
- SPIRIVA (Drug) $27.78
- remede System (Device) $21.62
- NIOX VERO DEVICE (Device) $20.54
- Arikayce (Drug) $17.60
- Prolastin-C Liquid (Biological) $16.66
- TRELEGY ELLIPTA (Drug) $15.00
- FASENRA (Biological) $6.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.